PAH TREATMENT IN THE PALM OF YOUR HAND
Taking a dose is as simple as:
JUST ONE BREATH—OPEN, LOAD, INHALE
TYVASO and TYVASO DPI are approved for the treatmentof pulmonary arterial hypertension (PAH; WHO Group 1) to improve the ability to exercise.
TYVASO is inhaled directly to the lungs, where it’s needed—and may give you the ability to walk farther and do more of what matters most to you. TYVASO is offered in 2 delivery options, including a dry powder inhaler (DPI) and a nebulizer.
CO-PAY ASSISTANCE PROGRAM
With the TYVASO Co-Pay Assistance Program, most eligible patients pay as little as a $0 co-pay for each prescription of TYVASO or TYVASO DPI.
I hope TYVASO will help you as it’s helped me.
– TYVASO Patient
Individual results may vary.